Nearly 40% have Long Covid after 7 months, finds Swiss study

Last update July 7, 2021

Investec July 7, 2021 SNB & CHF

by
Investec
My articles My books My videos
Follow on:Twitter

Summary:
The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months. © Wavebreakmedia Ltd | Dreamstime.com Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%). Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that

Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter

This could be interesting, too:

Investec writes Swiss to vote on tenancy laws this weekend

Eamonn Sheridan writes CHF traders note – Two Swiss National Bank speakers due Thursday, November 21

Charles Hugh Smith writes How Do We Fix the Collapse of Quality?

Marc Chandler writes Sterling and Gilts Pressed Lower by Firmer CPI

The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months.

Nearly 40% have Long Covid after 7 months, finds Swiss study

Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%).

Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that came, went, and returned later.

Of the 311 participants that responded at all 3 follow-up time points, 37% reported symptom resolution by 30 to 45 days and 19% by 7 to 9 months. 27% reported symptoms at all 3 time points and 10% reported symptoms at the start and at 7 to 9 months but not at 30 to 45 days. Finally, 4% of participants reported no symptoms at all 3 time points, 2% had no symptoms at baseline but had symptoms at 30 to 45 days and 7 to 9 months, and 1 person had no symptoms at the start and 30 to 45 days but had symptoms at 7 to 9 months.

The study authors concluded that residual symptoms following SARS-CoV-2 infection are common among otherwise young and healthy persons and recommend long-term monitoring.

The mean age of those studied was 42.1 years, 60.9% were women, 25.3% were health care workers, and 70.7% had no underlying risk factors.